Boehringer Ingelheim International GMBH vs The Controller Of Patents & Anr. on 12 July, 2022
Delhi High Court
Facts / Background
The Applicant, Boehringer Ingelheim International GMBH, had filed a National Phase PCT Application on 14th November, 2008, for 'Use of IV Inhibitors'. The patent specification had Claims numbered 1 - 18, with two claims numbered as 15, which were referred to as 15 and 15A.
The First Examination Report ("FER") was issued on 24th March, 2014, in response to…
After the establishment of the IP Division, the Delhi High Court has been clarifying different aspects of patent law through its lucid and well-written judgments. In a case decided on 12th July 2022, the Court has clarified and succinctly put together principles pertaining to the filing of divisional patent applications. While rejecting the validity of a divisional application including product claims pertaining to DPP IV inhibitors because the parent application included only use and process claims, the Court stated as…
“Interesting patents and designs based on Christmas, Invisible Christmas Tree, CII IP awards – TCS and Samsung awarded, Nike’s patented technology challenged by Adidas, Sprint sues Mediacom, Ericsson awarded 75 million dollars in damages, Qualcomm seeks ban on iPhone X, LG Electronics and InterDigital enter into patent licensing agreement, China becomes top patent filer in 2016, Requesting examination of a divisional application in India, Patent Tip of the Week and other Weekly Patent News” presented by the Patent attorneys and…